Letter: association of circulating bile acid concentrations and non-alcoholic fatty liver disease
- PMID: 35748845
- DOI: 10.1111/apt.16986
Letter: association of circulating bile acid concentrations and non-alcoholic fatty liver disease
Comment in
-
Letter: association of circulating bile acid concentrations and non-alcoholic fatty liver disease-authors' reply.Aliment Pharmacol Ther. 2022 Jul;56(2):374-375. doi: 10.1111/apt.17059. Aliment Pharmacol Ther. 2022. PMID: 35748838 No abstract available.
Comment on
-
Circulating bile acid concentrations and non-alcoholic fatty liver disease in Guatemala.Aliment Pharmacol Ther. 2022 Jul;56(2):321-329. doi: 10.1111/apt.16948. Epub 2022 Apr 28. Aliment Pharmacol Ther. 2022. PMID: 35484638 Free PMC article.
References
REFERENCES
-
- Rivera-Andrade A, Petrick JL, Alvarez CS, Graubard BI, Florio AA, Kroker-Lobos MF, et al. Circulating bile acid concentrations and non-alcoholic fatty liver disease in Guatemala. Aliment Pharmacol Ther. 2022;56:321-329.
-
- Horvatits T, Drolz A, Roedl K, Rutter K, Ferlitsch A, Fauler G, et al. Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis. Liver Int. 2017;37(2):224-31.
-
- Geier A. Hepatitis B virus: the "metabolovirus" highjacks cholesterol and bile acid metabolism. Hepatology. 2014;60(5):1458-60.
-
- Li T, Chiang JY. Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev. 2014;66(4):948-83.
-
- Luo L, Aubrecht J, Li D, Warner RL, Johnson KJ, Kenny J, et al. Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans. PLoS One. 2018;13(3):e0193824.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical